<?xml version="1.0" encoding="ISO-8859-1" ?><rss version="2.0"><channel><title>NIH Funding Opportunities (Notices, PA, RFA)</title><link>http://grants.nih.gov/grants/guide/WeeklyIndex.cfm</link><description>Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.</description><language>en-us</language><pubDate>Thu, 09 Feb 2012 03:13:51 EST</pubDate>     <item>      <title>Notice of Intent to Publish a Request for Applications for Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54)</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-AR-13-002.html</link>       <description>Notice NOT-AR-13-002 from the NIH Guide for Grants and Contracts</description>       <pubDate>Mon, 06 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Request for Information (RFI): Optimization of Information Technology for Biobanks Collecting Specimens from Clinical Trials Sponsored by the National Cancer Institute (NCI)   </title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-CA-12-008.html</link>       <description>Notice NOT-CA-12-008 from the NIH Guide for Grants and Contracts</description>       <pubDate>Mon, 06 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>NCI Will Participate in RFA-AR-12-007, "Ancillary Domain Development Patient-Reported Outcomes Measurement Information System (PROMIS) Studies (R01)."</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-CA-12-011.html</link>       <description>Notice NOT-CA-12-011 from the NIH Guide for Grants and Contracts</description>       <pubDate>Wed, 08 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>NIDCD Will Participate in PAR-09-220, "Innovations in Biomedical Computational Science and Technology Initiative" (SBIR [R43/R44])</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-DC-12-007.html</link>       <description>Notice NOT-DC-12-007 from the NIH Guide for Grants and Contracts</description>       <pubDate>Thu, 09 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Notice of Corrections for PAR-12-085 NIBIB Research Education Programs for Residents and Clinical Fellows (R25)  </title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-EB-12-002.html</link>       <description>Notice NOT-EB-12-002 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Notice of Termination of PAR-11-176, High-Throughput-Enabled Structural Biology Partnerships (U01)</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-GM-12-101.html</link>       <description>Notice NOT-GM-12-101 from the NIH Guide for Grants and Contracts</description>       <pubDate>Thu, 09 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Request for Information (RFI):  Updating the National Institutes of Health Research Plan on Fragile X Syndrome and Associated Disorders</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-HD-12-012.html</link>       <description>Notice NOT-HD-12-012 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Re-Activation of AHRQ Individual Career Development (K) Funding Opportunity Announcements (FOAs) for June 5, 2012 Receipt Date</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-HS-12-006.html</link>       <description>Notice NOT-HS-12-006 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Salary Limitation on FY2012 AHRQ Grants, Cooperative Agreements, and Contracts</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-HS-12-007.html</link>       <description>Notice NOT-HS-12-007 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Notice of a Change in Eligibility Criteria for Candidates for NOT-MH-11-014 - Notice of Availability of Administrative Supplements to Enable Continuity of Research Experiences of M.D./Ph.D.s During Clinical Training </title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-MH-12-018.html</link>       <description>Notice NOT-MH-12-018 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Request for Information (RFI): Input into the Scientific Strategic Plan for the proposed National Institute of Substance Use and Addiction Disorders</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-045.html</link>       <description>Notice NOT-OD-12-045 from the NIH Guide for Grants and Contracts</description>       <pubDate>Wed, 08 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Findings of Research Misconduct</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-046.html</link>       <description>Notice NOT-OD-12-046 from the NIH Guide for Grants and Contracts</description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Notice of Change to Non-Allowable Costs for PA-10-071: NIH Support for Conferences and Scientific Meetings [Parent R13/U13]</title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-048.html</link>       <description>Notice NOT-OD-12-048 from the NIH Guide for Grants and Contracts</description>       <pubDate>Thu, 09 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Notice Regarding NIH plan to Transition from use of USDA Class B Cats to Other Legal Sources   </title>       <link>http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-049.html</link>       <description>Notice NOT-OD-12-049 from the NIH Guide for Grants and Contracts</description>       <pubDate>Wed, 08 Feb 2012 12:00:00 EST</pubDate>      </item>       <item>      <title>Ancillary Domain Validation Patient-Reported Outcomes Measurement Information System (PROMIS) Studies (R01) </title>       <link>http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-12-007.html</link>       <description><![CDATA[       Funding Opportunity RFA-AR-12-007 from the NIH Guide for Grants and Contracts.       With this Funding Opportunity Announcement (FOA), the NIH solicits applications that propose to conduct ancillary studies intended to facilitate incorporation of PROMIS (Patient-Reported Outcomes Measurement Information System) domains into ongoing clinical projects in patient populations that represent the NIH portfolio of diseases (http://www.nih.gov).  The ongoing project can be a clinical trial, observational study or patient care population that can provide a sufficient cohort of well-characterized patients and has an existing infrastructure that can facilitate data collection and subsequent analysis.   In particular, NIH invites applications focusing on outcomes research to use PROMIS domains and encourages collaborative approaches and data-sharing with the PROMIS Network contributing to the further validation, testing, and evaluation of the existing PROMIS item banks in these populations.        ]]></description>       <pubDate>Mon, 06 Feb 2012 12:00:00 EST</pubDate>      </item>       <item>      <title>Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33)</title>       <link>http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-001.html</link>       <description><![CDATA[       Funding Opportunity RFA-DA-13-001 from the NIH Guide for Grants and Contracts.       This funding opportunity announcement (FOA) solicits applications for Phased Innovation (R21/R33) research projects to conduct rigorous, objective services research to monitor and examine changes in drug use prevention, addiction treatment, and associated HIV and viral hepatitis services, that may occur as a result of healthcare reform.  This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition of up to four years of expanded research support (R33 phase). The total project period for an application submitted in response to this FOA may not exceed five years.        ]]></description>       <pubDate>Mon, 06 Feb 2012 12:00:00 EST</pubDate>      </item>       <item>      <title>NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01)</title>       <link>http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-032.html</link>       <description><![CDATA[       Funding Opportunity RFA-DK-11-032 from the NIH Guide for Grants and Contracts.       The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) was established in July, 2002 for the purpose of identifying genes predisposing to IBD.Since its establishment, the IBDGC, in collaboration with other international IBD genetics consortia, has identified more than 100 such susceptibility loci.However, many susceptibility genes still remain to be identified, and the work of elucidating how IBD risk-associated genetic variants influence the pathophysiology of IBD has barely begun.The purpose of this FOA is to renew the IBDGC to continue the discovery of susceptibility variants, and to integrate genomic with epigenomic, transcriptomic, proteomic, metabolomic, and other -omic methodologies to elucidate the effects of genetic risk variants on the pathophysiology of IBD.The GRCs will serve as sites of enrollment of IBD patients, relatives, and healthy controls for these studies, and for laboratory-based studies on biological samples taken from these subjects.The PD(s)/PI(s) of the GRCs will serve as members of the Steering Committee of the IBDGC, which will be responsible for all of the IBDGC's operational decisions, which will be binding upon all of the IBDGC's members.      ]]></description>       <pubDate>Thu, 09 Feb 2012 12:00:00 EST</pubDate>      </item>       <item>      <title>Limited Competition for Data Coordinating Center (DCC) for NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U01)</title>       <link>http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-502.html</link>       <description><![CDATA[       Funding Opportunity RFA-DK-11-502 from the NIH Guide for Grants and Contracts.       The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) was established in July, 2002 for the purpose of identifying genes predisposing to IBD.Since its establishment, the IBDGC, in collaboration with other international IBD genetics consortia, has identified more than 100 such susceptibility loci.However, many susceptibility genes still remain to be identified, and the work of elucidating how IBD risk-associated genetic variants influence the pathophysiology of IBD has barely begun.The purpose of this FOA is to renew the IBDGC to continue the discovery of susceptibility variants, and to integrate genomic with epigenomic, transcriptomic, proteomic, metabolomic, and other -omic methodologies to elucidate the effects of genetic risk variants on the pathophysiology of IBD.The DCC will coordinate collaboration among the Genetic Research Centers (GRCs, described in accompanying RFA-DK-11-032), enrollment of subjects into the study, submission of blood and other biological samples to centralized repositories, processing of blood samples for extraction of DNA and immortalization of cell lines, submission of clinical, genetic, and molecular data to central databases, and analyses of data, and manage the operations of the Steering Committee and other operational committees. The PD(s)/PI(s) of the DCC shall serve as a voting member of the Steering Committee of the IBDGC, and be bound by all of the operational decisions of this Committee.      ]]></description>       <pubDate>Thu, 09 Feb 2012 12:00:00 EST</pubDate>      </item>       <item>      <title>Stem Cell Approaches to Developing New Therapies for Ocular Diseases (R01)</title>       <link>http://grants.nih.gov/grants/guide/rfa-files/RFA-EY-12-001.html</link>       <description><![CDATA[       Funding Opportunity RFA-EY-12-001 from the NIH Guide for Grants and Contracts.       The purpose of this FOA is to encourage the submission of applications proposing to use human stem cells to develop methods for generating replacement cells and transplantation techniques for the treatment of ocular diseases and disorders.  Studies may include elucidating the mechanisms required to direct stem cell differentiation into specialized ocular cell lineages.       ]]></description>       <pubDate>Tue, 07 Feb 2012 12:00:00 EST</pubDate>      </item>     <item>      <title>Development of Measures to Determine Successful Hearing Health Care Outcomes (R01)</title>       <link>http://grants.nih.gov/grants/guide/pa-files/PAR-12-101.html</link>       <description><![CDATA[       Funding Opportunity PAR-12-101 from the NIH Guide for Grants and Contracts.       The goal of this FOA is to encourage Research Project Grant (R01) applications that seek to identify the variables contributing to successful hearing health care outcomes in adults with hearing loss, and to develop and evaluate clinical measures of those variables.]]></description>       <pubDate>Thu, 09 Feb 2012 12:00:00 EST</pubDate>      </item></channel></rss>
